Active, Not Recruiting
TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors
NCT02142803
- Conditions
- Adnexal Diseases, Adult Glioblastoma, Astrocytoma, +47 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Massachusetts General Hospital Charlestown, Massachusetts, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States